Guangdong VTR Bio-Tech Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 753.88 million compared to CNY 871.15 million a year ago. Revenue was CNY 753.88 million compared to CNY 871.15 million a year ago.

Net income was CNY 15.56 million compared to CNY 60.44 million a year ago. Basic earnings per share from continuing operations was CNY 0.0317 compared to CNY 0.1233 a year ago. Diluted earnings per share from continuing operations was CNY 0.0317 compared to CNY 0.1231 a year ago.